News

Published on 22 Mar 2024 on Zacks via Yahoo Finance

Compelling Reasons to Hold on to UnitedHealth Group (UNH) Stock


Article preview image

UnitedHealth Group Incorporated UNH is currently aided by a growing customer base, contract wins, a well-performing Optum business and a solid financial position. An optimistic 2024 outlook also reinforces investors’ confidence in the stock.

Zacks Rank & Price Rally

UnitedHealth Group currently carries a Zacks Rank #3 (Hold).

NYSE.UNH price evolution
NYSE.EW price evolution
NASDAQ.DXCM price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
DexCom (DXCM) to Report Q1 Earnings: What's in the Cards?

DexCom, Inc. DXCM is scheduled to release first-quarter 2024 results on Apr 25, after the closing...

Zacks via Yahoo Finance 23 Apr 2024

DexCom Insiders Sold US$18m Of Shares Suggesting Hesitancy

Many DexCom, Inc. (NASDAQ:DXCM) insiders ditched their stock over the past year, which may be of ...

Simply Wall St. via Yahoo Finance 22 Apr 2024

Zacks Investment Ideas feature highlights: Vertiv, Align Technology and DexCom

For Immediate Release Chicago, IL – April 22, 2024 – Today, Zacks Investment Ideas feature highl...

Zacks via Yahoo Finance 22 Apr 2024

11 Hot Growth Stocks To Buy Right Now

In this article, we discuss the 11 hot growth stocks to buy now. If you want to read about some m...

Insider Monkey via Yahoo Finance 21 Apr 2024

6 portfolio stock earnings and the Fed's favorite inflation gauge dominate the week ahead

We're also going to continue to watch Israel and Iran tensions as well as the continued fighting ...

CNBC 20 Apr 2024

3 Innovative Stocks to Buy Before Earnings Amid the Market Pullback

Today’s episode of Full Court Finance at Zacks dives into the recent stock market pullback. We th...

Zacks via Yahoo Finance 19 Apr 2024

Reasons to Retain DexCom (DXCM) Stock in Your Portfolio for Now

DexCom, Inc. DXCM is well poised for growth in the coming quarters, backed by its strong product ...

Zacks via Yahoo Finance 18 Apr 2024

EVP Strategy and Corporate Dev Matthew Dolan Sells Shares of DexCom Inc (DXCM)

EVP Strategy and Corporate Development Matthew Dolan has sold 1,990 shares of DexCom Inc (NASDAQ:...

GuruFocus.com via Yahoo Finance 16 Apr 2024

Zacks Industry Outlook Highlights Edwards Lifesciences, DexCom and STERIS

For Immediate Release Chicago, IL – April 16, 2024 – Today, Zacks Equity Research discusses Edwar...

Zacks via Yahoo Finance 16 Apr 2024

DexCom (DXCM), MD Revolution Unite to Boost Diabetes Management

DexCom Inc. DXCM and MD Revolution recently announced their partnership, where Dexcom is likely t...

Zacks via Yahoo Finance 15 Apr 2024